Tiantan bio diagnostic supplies and other biological products
Tiantan Bio is a vaccine reagent developer, focusing on the research and production of vaccines, blood preparations, diagnostic supplies and other biological products, mainly to provide users with hepatitis B vaccine, polio vaccine, MMR vaccine, influenza vaccine, chickenpox vaccine and other products, its own Changchun Chijian Biological Products Co.
Black Swans and Breakthroughs: China's Top 50 Innovative Public Firms in 2020
In the times of crisis like COVID-19, even established companies risk falling due to the sudden drop in their income. By contrast, companies that cling to innovation may unlock more value as they fight against the challenges.
Oct 20, 2020 07:40 PM
After China's BNR and GTH Hit Nasdaq, Pan-Cancer Detector GRAIL Eyes IPO
The early-stage cancer-detection technology has declared its mission: to take on and defeat the fatal illness, for the benefit of humanity. Following Burning Rock and Genetron Health, the US biotech GRAIL looks to go public on Nasdaq.
Sep 10, 2020 11:48 AM
Bid for Molecular Tech in China's Early-Stage Cancer Detection Market
China, with a population of 1.4 billion, has one of the largest gene pools in the world. How does its DNA tech-based cancer detection industry look? Listed on Nasdaq in 2020, Genetron Holdings Limited (Genetron Health) is taking a leading role.
Sep 09, 2020 03:08 PM
More Room for the Medical Device Market to Grow in China
The medical device market in China is substantial – it also has massive niche markets. The domestic market size growth has surpassed that of the global market for many years, showing strong potential for development.
Aug 29, 2020 08:24 AM
Modern Chinese Medicine Maker Tasly Pharmaceutical: An Old Stock in a New Package?
Tasly Pharmaceutical, founded in 1994 and listed on SSE in 2002, is valued at CNY 26.9 billion – a market cap that the company once achieved ten years ago. But did the company merely spin in circles during the last decade?
Jul 12, 2020 12:00 PM
Haier Balances Smart Home Demand at Home and Overseas Trends
Haier Smart Home (600690:SZ), one of the three leading home appliances brands in China, is undergoing a business transformation. We are aiming to evaluate how Haier’s key business drivers are performing with the current COVID-19 situation.
Jun 23, 2020 12:10 PM
TuSimple: Start with the Low-Hanging Fruit
TuSimple is dedicated to bringing the most cost-effective autonomous driving solutions to shippers and logistic companies in both China and America. Their obsession with cost control has given them a head start on commercialization.
Jun 23, 2020 11:00 AM
Burning Rock Hits NASDAQ, Still Struggles to Make a Profit
NASDAQ welcomes its first Chinese NGS cancer detection company, Burning Rock. The company owns the largest market share in Chinese NGS market but still hasn’t begun to profit. What is the cause and how long does it still need?
Jun 19, 2020 10:20 AM
Autonomous Driving and Electric Vehicles: BAIC BJEV
To respond to the increasingly febrile new energy vehicle market, manufacturer BJEV is focusing on autonomous driving technology and high-end models, which are directly competing with Tesla.
Jun 15, 2020 07:14 AM
Beyond the Cashless Society: Chinese Professors Explain Central Bank Digital Currency
We talked to China’s top financial technologies expert David Wen – who coined the term ‘digital fiat currency’ in 2017 – and Dr. Ben Shenglin, the Dean of the Zhejiang University International Business School.
Jun 12, 2020 03:35 PM
Where to Go: Transsion’s Post-epidemic Survival Conundrum
The African continent has failed to escape from the hardships brought by COVID-19. Will Transsion, the local handset market leader, share the same fate in the post-epidemic future?
Jun 12, 2020 02:43 PM
- The Sunrise and ‘Moonrise’ for Transsion: Opportunities and Upcoming Threats
- WuXi AppTec: A Favorable Chinese Stock for MSCI and FTSE Russell
- Meinian Onehealth: Check-up Giant in Hot Waters
- The Road May Be Long, but iSpace Knows to Keep Moving
- Huawei’s W. Genovese on the User’s Perspective, Fintech and 5G